Eloxx Pharmaceuticals Inc (ELOX)
0.9161
+0.10
(+12.64%)
USD |
OTCM |
May 10, 15:34
Eloxx Pharmaceuticals Cash from Financing (TTM): -2.09M for Sept. 30, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
September 30, 2023 | -2.09M |
June 30, 2023 | -4.26M |
March 31, 2023 | -5.688M |
December 31, 2022 | 8.812M |
September 30, 2022 | 8.34M |
June 30, 2022 | 10.20M |
March 31, 2022 | 56.53M |
December 31, 2021 | 50.79M |
September 30, 2021 | 49.70M |
June 30, 2021 | 45.09M |
March 31, 2021 | -1.693M |
December 31, 2020 | -3.438M |
September 30, 2020 | -1.667M |
June 30, 2020 | -0.536M |
March 31, 2020 | 32.22M |
December 31, 2019 | 46.80M |
September 30, 2019 | 48.79M |
June 30, 2019 | 48.91M |
March 31, 2019 | 70.28M |
December 31, 2018 | 56.18M |
September 30, 2018 | 55.18M |
June 30, 2018 | 55.47M |
March 31, 2018 | 2.30M |
September 30, 2017 | 2.60M |
June 30, 2017 | 1.10M |
Date | Value |
---|---|
March 31, 2017 | 0.80M |
December 31, 2016 | 0.30M |
September 30, 2016 | 0.00 |
June 30, 2016 | 1.152M |
March 31, 2016 | 5.98M |
December 31, 2015 | 5.98M |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | 8.73M |
June 30, 2014 | 8.730M |
March 31, 2014 | 9.757M |
December 31, 2013 | 10.80M |
September 30, 2013 | 3.939M |
June 30, 2013 | 4.033M |
March 31, 2013 | 2.94M |
December 31, 2012 | 2.849M |
September 30, 2012 | 2.871M |
June 30, 2012 | 3.228M |
March 31, 2012 | 3.241M |
December 31, 2011 | 1.986M |
September 30, 2011 | 2.113M |
June 30, 2011 | 1.662M |
March 31, 2011 | 12.39M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-5.688M
Minimum
Mar 2023
56.53M
Maximum
Mar 2022
21.49M
Average
9.504M
Median
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.625M |
Oragenics Inc | 0.2839M |